Ajanta Pharma

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Ajanta Pharma Limited
Public Company
Traded as
IndustryPharmaceuticals, Drugs & Healthcare
Key people
Yogesh Agrawal, Managing Director. Rajesh Agrawal, Joint Managing Director
ProductsBranded Generic Formulations / Medicines
RevenueIncrease 2,155 crore (US$300 million) (2017–2018)
Number of employees
SubsidiariesAjanta Pharma (Mauritius) Ltd,

Ajanta Pharma Philippines Inc., Ajanta Pharma USA Inc.,

Ajanta Pharma Nigeria Ltd.[2]
Websitewww.ajantapharma.com/ Edit this on Wikidata

Ajanta Pharma Limited (APL) is an multinational company based in India engaged in development, manufacturing, and marketing of pharmaceutical formulations. It has a presence in India, the United States, and about 30 other countries in Africa, Asia, Middle East, and CIS. It was established in 1973.

Markets and business[edit]

Ajanta Pharma has over 1,400 products registered currently in various countries and equal number of products are under approval. In India, the company is a branded generic company focused on a few high growth specialty therapies in ophthalmology, dermatology, cardiology, and pain management.

Ajanta Pharma exports products to over 30 countries in Asia and Africa. In these markets, the company serves a wide range of therapeutic products in the areas of antimalarial, cardiovascular, gastrointestinal, antibiotic, dermatology, antihistamine, multivitamin, gynecology, and pain management.

Ajanta Pharma has recently stepped up its presence in the United States with a select product portfolio, which includes niche and complex technology products. Currently, the company has 21 products in the US market.{[3]}

Manufacturing facilities[edit]

Ajanta Pharma operates seven manufacturing facilities; six within India and one in Mauritius. In India, five facilities manufacture finished formulations, including Dahej and Paithan plants which is approved by US FDA and Guwahati plant which caters to domestic and emerging markets. Another plant manufactures active pharmaceutical ingredients (APIs) primarily for captive consumption.


  1. ^ "Welcome To Ajanta Pharma". Ajantapharma.com. Retrieved 29 February 2016.
  2. ^ "Ajanta Pharma Limited - Our Business". Company. Retrieved 29 February 2016.
  3. ^ http://www.ajantapharma.com/AdminData/Results/Q3FY2019PressReleaseandResults.pdf

External links[edit]